Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000525211 | SCV000653559 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001551628 | SCV001772170 | likely benign | not provided | 2021-03-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001551628 | SCV001962406 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | RTEL1: BP4, BP7, BS2 |
Sema4, |
RCV002255461 | SCV002535276 | likely benign | Dyskeratosis congenita | 2021-02-13 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002448784 | SCV002732204 | likely benign | Inborn genetic diseases | 2022-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001551628 | SCV005210169 | likely benign | not provided | criteria provided, single submitter | not provided |